222 related articles for article (PubMed ID: 4131034)
1. Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man.
Peacock M; Gallagher JC; Nordin BE
Lancet; 1974 Mar; 1(7854):385-89. PubMed ID: 4131034
[No Abstract] [Full Text] [Related]
2. Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
Henderson RG; Russell RG; Ledingham JG; Smith R; Oliver DO; Walton RJ; Small DG; Preston C; Warner GT
Lancet; 1974 Mar; 1(7854):379-84. PubMed ID: 4131033
[No Abstract] [Full Text] [Related]
3. 1 alpha-hydroxyvitamin D3 in intestinal calcium malabsorption. A pilot study.
Hylander E; Jarnum S
Scand J Gastroenterol; 1980; 15(4):443-8. PubMed ID: 7433906
[TBL] [Abstract][Full Text] [Related]
4. Possible function of different renal metabolites of vitamin D in man.
Kanis JA; Cundy T; Smith R; Heynen G; Warner GT; Lorains J; Russell RG
Contrib Nephrol; 1980; 18():192-211. PubMed ID: 7353376
[No Abstract] [Full Text] [Related]
5. Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.
Bordier P; Pechet MM; Hesse R; Marie P; Rasmussen H
N Engl J Med; 1974 Oct; 291(17):866-71. PubMed ID: 4415589
[No Abstract] [Full Text] [Related]
6. [Recent aspects on regulation of calcium metabolism. I. Vitamin D].
Nielsen SP
Ugeskr Laeger; 1973 Nov; 135(46):2504-7. PubMed ID: 4361021
[No Abstract] [Full Text] [Related]
7. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
[TBL] [Abstract][Full Text] [Related]
8. Biologic effects of short-term phenobarbital treatment on the response to vitamin D and its metabolites in the chick.
Norman AW; Bayless JD; Tsai HC
Biochem Pharmacol; 1976 Jan; 25(2):163-8. PubMed ID: 177022
[No Abstract] [Full Text] [Related]
9. [Biological activity of 1alpha-hydroxycholecalciferol (1). Effect on intestine and bone in rats (author's transl)].
Kawashima H; Hoshina K; Saitoh N; Okamiya Y; Hashimoto Y; Ishimoto S; Noguchi T; Orimo H
Nihon Yakurigaku Zasshi; 1978 Mar; 74(2):267-83. PubMed ID: 658840
[TBL] [Abstract][Full Text] [Related]
10. 25-Azavitamin D3, an inhibitor of vitamin D metabolism and action.
Onisko BL; Schnoes HK; DeLuca HF
J Biol Chem; 1979 May; 254(9):3493-6. PubMed ID: 218970
[TBL] [Abstract][Full Text] [Related]
11. Intestinal phosphate absorption in normal and uremic man: effects of 1,25(OH)2-vitamin D3 and 1alpha(OH)-vitamin D3.
Coburn JW; Brickman AS; Hartenbower DL; Norman AW
Adv Exp Med Biol; 1977; 81():549-57. PubMed ID: 899939
[No Abstract] [Full Text] [Related]
12. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
13. [Methods of estimation of vitamin D supply in humans].
Spirichev VB
Vopr Pitan; 1981; (5):3-8. PubMed ID: 7032070
[No Abstract] [Full Text] [Related]
14. 1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.
Russell RG; Smith R; Walton RJ; Preston C; Basson R; Henderson RG; Norman AW
Lancet; 1974 Jul; 2(7871):14-7. PubMed ID: 4134407
[No Abstract] [Full Text] [Related]
15. I alpha-hydroxycholecalciferol: a treatment of renal bone disease.
Catto GR; MacLeod M; Pelc B; Kodicek E
Br Med J; 1975 Jan; 1(5948):12-4. PubMed ID: 1120218
[TBL] [Abstract][Full Text] [Related]
16. Effect of 25-hydroxycholecalciferol (25-HCC) on intestinal absorption of 47Ca in four cases of iatrogenic Cushing's syndrome.
Caniggia A; Gennari C
Helv Med Acta; 1973 Oct; 37(4):221-5. PubMed ID: 4357902
[No Abstract] [Full Text] [Related]
17. The effect of plasma phosphate on the action of 1alphaOHD3 in haemodialysis patients.
Peacock M; Davison AM; Walker GS
Adv Exp Med Biol; 1977; 81():559-69. PubMed ID: 899940
[No Abstract] [Full Text] [Related]
18. Role of 1,25-dihydroxycholecalciferol in calcification of bone and maintenance of serum calcium concentration in the rat.
Tanaka Y; Frank H; DeLuca HF
J Nutr; 1972 Dec; 102(12):1569-77. PubMed ID: 4344034
[No Abstract] [Full Text] [Related]
19. Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.
von Herrath D; Schaefer K; Kraft D; Grigoleit HG; Koeppe P
Klin Wochenschr; 1973 Oct; 51(19):979-81. PubMed ID: 4762587
[No Abstract] [Full Text] [Related]
20. Editorial: Role of the kidney in the metabolism of calciferol (vitamin D).
Coburn JW; Norman AW
Clin Nephrol; 1973; 1(5):273-83. PubMed ID: 4358418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
